Effect of Daptomycin on Local Interleukin-6, Matrix Metalloproteinase-9, and Metallopeptidase Inhibitor 1 in Patients With MRSA-Infected Diabetic Foot

Mechanisms Involved in the Development and Healing of Diabetic Foot Ulceration

(2012) T. Dinh et al.   DIABETES

Superficial Wound Swabbing: A novel method of sampling and processing wound fluid for subsequent immunoassay analysis in diabetic foot ulcerations

(2012) M. Schmohl et al.   DIABETES CARE

Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost

(2010) B. A. Lipsky et al.   DIABETOLOGIA

Changing microbiological profile of pathogenic bacteria in diabetic foot infections: time for a rethink on which empirical therapy to choose?

(2010) P. Ramakant et al.   DIABETOLOGIA

Interleukin-6 concentrations in wound fluids rather than serological markers are useful in assessing bacterial triggers of ulcer inflammation

(2010) Andreas Ambrosch et al.   International Wound Journal

Evaluation of Vancomycin and Daptomycin Potency Trends (MIC Creep) against Methicillin-Resistant Staphylococcus aureus Isolates Collected in Nine U.S. Medical Centers from 2002 to 2006

(2009) H. S. Sader et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Risk factors and healing impact of multidrug-resistant bacteria in diabetic foot ulcers

(2008) J.-L. Richard et al.   DIABETES & METABOLISM

Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers

(2008) Y. Liu et al.   DIABETES CARE

Factors associated with treatment failure in patients with diabetic foot infections: An analysis of data from randomized controlled trials

(2008) Konstantinos Z. Vardakas et al.   DIABETES RESEARCH AND CLINICAL PRACTICE